NasdaqCM - Delayed Quote USD
ImmunoPrecise Antibodies Ltd. (IPA)
0.5700
-0.0042
(-0.73%)
At close: May 30 at 4:00:01 PM EDT
0.5750
+0.00
+(0.88%)
After hours: May 30 at 7:55:26 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CAD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 2 | 1 |
| Avg. Estimate | 7.89M | 6.4M | 25.43M | 29M |
| Low Estimate | 7.2M | 6.4M | 24.74M | 29M |
| High Estimate | 8.58M | 6.4M | 26.12M | 29M |
| Year Ago Sales | 6.46M | 5.26M | 24.52M | 25.43M |
| Sales Growth (year/est) | 22.16% | 21.60% | 3.72% | 14.06% |
Earnings History
| Currency in USD | 4/30/2024 | 7/31/2024 | 10/31/2024 | 1/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.08 | -0.07 | -0.06 |
| EPS Actual | -0.1 | -0.11 | -0.06 | -0.46 |
| Difference | -0.02 | -0.03 | 0.01 | -0.41 |
| Surprise % | -23.19% | -38.72% | 8.30% | -724.88% |
EPS Trend
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Apr 2025) | Next Qtr. (Jul 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IPA | -- | -- | -- | -- |
| S&P 500 | 13.07% | 2.27% | 7.37% | 14.07% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/11/2025 |
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 4/1/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/14/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 12/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/17/2024 |
Related Tickers
SLXN Silexion Therapeutics Corp
1.0400
+8.33%
SILO Silo Pharma, Inc.
0.4444
-5.97%
TNFA TNF Pharmaceuticals, Inc.
0.1604
-3.14%
INDP Indaptus Therapeutics, Inc.
0.3380
-15.50%
ELEV Elevation Oncology, Inc.
0.3001
-1.96%
WINT Windtree Therapeutics, Inc.
0.7610
-3.67%
ABP Abpro Corporation
0.2137
-8.28%
CERO CERo Therapeutics Holdings, Inc.
0.4454
-13.85%
GOVX GeoVax Labs, Inc.
1.0200
-4.67%
ABOS Acumen Pharmaceuticals, Inc.
1.0200
-2.86%